professionaladviser_logo

FOR SUSTAINABLE, PROFITABLE, CLIENT-FOCUSED ADVISER FIRMS

pin Sign in Join
pin
    • My account
    • Sign out
  • You are currently accessing Professional Adviser via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0) 1858 438800

    Email: [email protected]

    • Sign in
logo
  • logo

    Search Professional Adviser

  • News
  • More

    Choose from below

    • Features
    • Opinion
    • Editor's View
    • People Moves
    • Market Movers
    • Feel Good Friday
    • Professional Adviser TV
  • Your Business
    • Recruitment
    • Platforms
    • MPS
    • Education
    • Technology
    • Paraplanning
    • Diversity
    • Succession planning
  • Your Profession
    • Pensions
    • Investment
    • Regulation
    • ESG
    • Protection
    • Estate planning
    • Tax planning
    • Retirement
  • Consumer Duty
  • Events
  • About

    Authors

    • Jen Frost
    • Jenna Brown
    • Sahar Nazir
    • Isabel Baxter

    Featured Content

    • Cost of Living
    • Partner Insight
    • InvestmentIQ
    • PA360 Watchlist

    Sister publications

    • BusinessGreen
    • COVER
    • Investment Week
    • Professional Pensions

    Incisive Media

    • Our company
    • Careers
  • Searchlogo

    Search Professional Adviser

    x
Join Sign in
 
    • My account
    • Sign out
  • You are currently accessing Professional Adviser via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0) 1858 438800

    Email: [email protected]

    • Sign in
    • Sign in

National Institute for Health and Clinical Excellence (NICE)

PMI

Breast cancer drugs blocked from NHS

Two more cancer drugs have been provisionally banned for NHS after it was decided they were too expensive for the potential results.

clock 14 February 2012 •

Critical Illness

Cost of cancer to soar by two thirds in next decade

Britain will be facing a bill of more than £15bn a year to diagnose and treat cancer in ten years time, new research has suggested.

clock 12 December 2011 •

PMI

NICE publishes end of life care rules

The National Institute for Health and Clinical Excellence (NICE) has finalised new quality standards for end of life care for patients and their families and carers.

clock 30 November 2011 •

PMI

Nice rejects another breast cancer drug

The National Institute for Health and Clinical Excellence (Nice) has banned another breast cancer drug from routine NHS use.

clock 10 November 2011 •

Protection

Interview - Fergus Craig

Axa PPP's Fergus Craig has a keen eye on PMI. Paul Robertson asks him how the market is improving.

clock 17 October 2011 •
  • Contact Us
  • Marketing Solutions
  • About Incisive Media
  • Privacy Settings
  • Careers
  • Terms & Conditions
  • Policies
FOLLOW US
Incisive Media

© Incisive Business Media Limited, Published by Incisive Business Media Limited, New London House, 172 Drury Lane, London WC2B 5QR. Registered in England and Wales with company registration number 09178013. Part of Arc network, www.arc-network.com

DIGITAL PUBLISHER OF THE YEAR
right wallpaper ad
Loading.gif?page type=listing page&tag=national institute for health and clinical excellence nice